Merck Stock News

These five names are showing relative strength.

The "Sell in May and go away" adage suggests selling stocks in May and returning in November, but historical data shows that June and July have been strong months. September is consistently the worst

Griffin appears to have made a big bet in Q1 that Chevron's acquisition of Hess will sail through. His Citadel hedge fund bought over 22.4 million additional shares of Bank of America.

Vaccination of boys and men against the human papillomavirus (HPV) reduces their risk of head and neck cancers and other malignancies, a new analysis shows, adding to the vaccine's proven benefit in p

A vaccine that's widely known to help protect women from cervical cancer can also offer big health benefits for men, new research shows.

Wall Street investors are looking for cheap stocks to buy before the summer holiday period. Despite the rally we have witnessed so far in the year, risks like increased market volatility and uncertain

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Merck (MRK) stock is being driven by the strong sales of key products like Keytruda and Gardasil and positive pipeline and regulatory developments.

The Dow Jones touched the milestone of 40,000 for the first time on strong corporate earnings and renewed bets for rate cuts. We have highlighted five ETFs that have been leading the way higher this y

With the market potentially entering a period of consolidation, investors may want to consider safe haven stocks to buy. No, it's not the most exciting idea.

Here we discuss three drugmakers, Eli Lilly and Company (LLY), Novo Nordisk (NVO) and Merck (MRK), that have raised their earnings as well as sales guidance for 2024.

Merck (MRK) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, MRK broke through the 20-day moving average, which suggests a short-term

Merck & Co., Inc. (NYSE:MRK ) BofA Securities 2024 Health Care Conference May 15, 2024 4:40 PM ET Company Participants Caroline Litchfield - EVP & CFO Conference Call Participants Geoff Meacham - Bank

2 Fortune 100 Best Co's To Work For Are Also Good To Own

Joe Terranova, Senior Managing Director for Virtus Investment Partners, joins CNBC's "Halftime Report" to detail his latest buys